Cargando…
Targeted therapies to improve CFTR function in cystic fibrosis
Cystic fibrosis is the most common genetically determined, life-limiting disorder in populations of European ancestry. The genetic basis of cystic fibrosis is well established to be mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that codes for an apical membrane chl...
Autores principales: | Brodlie, Malcolm, Haq, Iram J., Roberts, Katie, Elborn, J. Stuart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582929/ https://www.ncbi.nlm.nih.gov/pubmed/26403534 http://dx.doi.org/10.1186/s13073-015-0223-6 |
Ejemplares similares
-
Precision Medicine Based on CFTR Genotype for People with Cystic Fibrosis
por: Haq, Iram, et al.
Publicado: (2022) -
The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022) -
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2018) -
Trends in nontuberculous mycobacteria infection in children and young people with cystic fibrosis
por: Abidin, Noreen Zainal, et al.
Publicado: (2021) -
Cystic Fibrosis, CFTR, and Colorectal Cancer
por: Scott, Patricia, et al.
Publicado: (2020)